| Overview |
| bs-6556R |
| OCC1 Polyclonal Antibody |
| ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human OCC1 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| Cytoplasm |
| C12orf75; Chromosome 12 open reading frame 75; Hypothetical protein LOC387882; MGC148100; MGC149157; OCC 1; OCC-1; Putative overexpressed in colon carcinoma 1 protein; OCC1_HUMAN. |
| OCC1 was initially identified as a novel human cDNA overexpressed in a colon carcinoma cell line. Elevated levels of OCC1 mRNA were observed in three of eight colon carcinomas, suggesting that OCC1 may be a hallmark of only a subset of colon carcinomas. It is highly expressed in skeletal muscle, kidney, placenta, and pancreas tissues, with low to no expression in heart, brain, lung and liver tissues. At least two different OCC1 mRNA species are known to exist. |
| Application Dilution |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz